In recent work by Gleich et al., cancer cells with lower APC activity demonstrated higher sensitivity to inhibition of KIF18A and when APC activity was increased in these cell lines, the sensitivity to KIF18A depletion was diminished. The gene discussed is APC; the disease is cancer.